Literature DB >> 7021422

Inhibition of nonspecific tumoricidal activity by activated macrophages with antiserum against a soluble cytotoxic factor.

D N Männel, W Falk, M S Meltzer.   

Abstract

Mouse peritoneal macrophages activated for tumor cytotoxicity by any of several in vivo or in vitro treatments released a soluble cytotoxin into culture fluids only after exposure to small amounts of bacterial lipopolysaccharides. This cytotoxic factor was physicochemically similar to the cytotoxic factor (tumor necrosis factor) in sera of BCG-infected mice injected with lipopolysaccharide. A rabbit antiserum against partially purified serum cytotoxic factor also inhibited the activity of macrophage-derived cytotoxic factor. Of special interest was the observation that rabbit anti-cytotoxic factor inhibited the cytotoxic activity of macrophages both in the presence and in the absence of exogenously added lipopolysaccharide. Inhibition was not complete but was consistent in all experiments. Thus, cytotoxic factor was implicated as a possible effector molecule in the nonspecific tumoricidal activity of activated macrophages.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7021422      PMCID: PMC350670          DOI: 10.1128/iai.33.1.156-164.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

1.  Interaction of BCG-activated macrophages with neoplastic and noneoplastic cell lines in vitro: cinemicrographic analysis.

Authors:  M S Meltzer; R W Tucker; A C Breuer
Journal:  Cell Immunol       Date:  1975-05       Impact factor: 4.868

2.  Regulation of lymphocyte-activating factor (LAF) production and secretion in P388D1 cells: identification of high molecular weight precursors of LAF.

Authors:  S B Mizel; D L Rosenstreich
Journal:  J Immunol       Date:  1979-06       Impact factor: 5.422

3.  Stimulation of RNA synthesis in L-929 cells by rabbit tumor necrosis factor.

Authors:  J M Ostrove; G E Gifford
Journal:  Proc Soc Exp Biol Med       Date:  1979-03

4.  Chemical, physical, biological properties of a lipopolysaccharide from Escherichia coli K-235.

Authors:  F C McIntire; H W Sievert; G H Barlow; R A Finley; A Y Lee
Journal:  Biochemistry       Date:  1967-08       Impact factor: 3.162

5.  Interaction of BCG-activated macrophages with neoplastic and nonneoplastic cell lines in vitro : quantitation of the cytotoxic reaction by release of tritiated thymidine from prelabeled target cells.

Authors:  M S Meltzer; R W Tucker; K K Sanford; E J Leonard
Journal:  J Natl Cancer Inst       Date:  1975-05       Impact factor: 13.506

6.  An endotoxin-induced serum factor that causes necrosis of tumors.

Authors:  E A Carswell; L J Old; R L Kassel; S Green; N Fiore; B Williamson
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

7.  Interaction of Bacillus Calmette--Guérin-activated macrophages and neoplastic cells in vitro II. The relationship of selective binding to cytolysis.

Authors:  P A Marino; D O Adams
Journal:  Cell Immunol       Date:  1980-08-15       Impact factor: 4.868

8.  Macrophages as a source of tumoricidal activity (tumor-necrotizing factor).

Authors:  D N Männel; R N Moore; S E Mergenhagen
Journal:  Infect Immun       Date:  1980-11       Impact factor: 3.441

9.  Generation and characterization of a lipopolysaccharide-induced and serum-derived cytotoxic factor for tumor cells.

Authors:  D N Männel; M S Meltzer; S E Mergenhagen
Journal:  Infect Immun       Date:  1980-04       Impact factor: 3.441

10.  Induction of macrophage plasminogen activator by endotoxin stimulation and phagocytosis: evidence for a two-stage process.

Authors:  S Gordon; J C Unkeless; Z A Cohn
Journal:  J Exp Med       Date:  1974-10-01       Impact factor: 14.307

View more
  15 in total

1.  Immunoreactivity for IL-1 beta and TNF alpha in human lymphoid and nonlymphoid tissues.

Authors:  L P Ruco; A Stoppacciaro; D Pomponi; D Boraschi; A Santoni; A Tagliabue; S Uccini; C D Baroni
Journal:  Am J Pathol       Date:  1989-11       Impact factor: 4.307

2.  The role of monocyte cytotoxic factor in monocyte-mediated lysis of tumour cells.

Authors:  T Espevik; O Kildahl-Andersen; J Nissen-Meyer
Journal:  Immunology       Date:  1986-02       Impact factor: 7.397

3.  Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone.

Authors:  T M Folks; K A Clouse; J Justement; A Rabson; E Duh; J H Kehrl; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

4.  Optimal induction of tumor necrosis factor production in human monocytes requires complete S-form lipopolysaccharide.

Authors:  D N Männel; W Falk
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

5.  Suppression of both macrophage-mediated tumor cell lysis and cytolytic factor production by a factor (CIF) derived from normal embryonic fibroblasts.

Authors:  R Gallily; G E Gifford; J Loewenstein
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

6.  Possible role of endotoxin in mediating host resistance.

Authors:  D N Männel
Journal:  Klin Wochenschr       Date:  1982-07-15

7.  Macrophage cytotoxicity in lethal and non-lethal murine malaria and the effect of vaccination.

Authors:  J Taverne; J D Treagust; J H Playfair
Journal:  Clin Exp Immunol       Date:  1986-10       Impact factor: 4.330

8.  Macrophage-mediated cytotoxicity: role of a soluble macrophage cytotoxic factor similar to lymphotoxin and tumor necrosis factor.

Authors:  C M Zacharchuk; B E Drysdale; M M Mayer; H S Shin
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

9.  Physicochemical characterization of cytostatic factors released from human monocytes.

Authors:  J Nissen-Meyer; J Hammerstrøm
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

10.  Further studies on the differences in cytotoxicity of human peripheral blood monocytes and bronchoalveolar macrophages for cultured human lung cells.

Authors:  S Swinburne; M Moore; P Cole
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.